AstraZeneca rejected close to £80mn in state support for cancelled Speke factory

ResidentialBusiness · 2025-02-03T05:00:53+0000

UK’s most valuable listed company raised NHS rejection of its new breast cancer drug and the drug pricing mechanism during negotiationsView the full article

By ResidentialBusiness
February 3 in Managing Contracts and Invoices

https://residentialbusiness.com/income/topic/2086-astrazeneca-rejected-close-to-%C2%A380mn-in-state-support-for-cancelled-speke-factory/

Followers 0

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

× Pasted as rich text. Paste as plain text instead

Only 75 emoji are allowed.

× Your link has been automatically embedded. Display as a link instead

× Your previous content has been restored. Clear editor

× You cannot paste images directly. Upload or insert images from URL.

Insert image from URL

https://residentialbusiness.com/income/topic/2086-astrazeneca-rejected-close-to-%C2%A380mn-in-state-support-for-cancelled-speke-factory/

Followers 0

Go to topic listing

Sign In

AstraZeneca rejected close to £80mn in state support for cancelled Speke factory

Recommended Posts

ResidentialBusiness

Join the conversation